 |
 |
Diethylstilbestrol (DES) is a drug once prescribed during pregnancy to
prevent miscarriages or premature deliveries. In the U.S. an estimated 5 to
10 million persons were exposed to DES from 1938 to 1971, including
pregnant women prescribed DES and their children. In 1971, the Food and
Drug Administration (FDA) advised physicians to stop prescribing DES
because it was linked to a rare vaginal cancer.
After more than 30 years of research, there are confirmed health risks associated with DES
exposure. However, not all exposed individuals will experience
DES-related health problems. Whether you know for sure or suspect you
were exposed to DES, you can use CDC's DES Update to learn more about DES
exposure and what you can do about it.
|
|
|
|
DES
Spotlight's |
|
|
|
|
Upcoming Event
27th Annual Meeting of the California
Association for Nurse Practitioners, March
25-28, 2004 in Monterey California at the DoubleTree Monterey and Conference Center. Nora
Cody, MA Executive Director of DESAction USA
will be presenting.
For more information please visit
www.canpweb.org.
CDC's DES Update Campaign Wins Award
Each year the Public Relations Society of
America (PRSA), Georgia Chapter, gives out
awards to recognize excellence among the state’s
public relations practitioners. The awards were
first given out in 1984. The 2003 award
recognizes work that was released, published or
performed between July 1, 2002 and June 30,
2003.
This year in the Public Service category, Porter
Novelli won the Phoenix Award for “Centers for
Disease Control and Prevention’s DES Update
Campaign.” The award was given out on November 6, 2003
at the Four Seasons Hotel, Atlanta.
We would like to acknowledge all of our partners
who were instrumental in the development of the
health education campaign. |
|
|
|
|
|
|
For Consumers
 Helpful information on DES research and a guide to help assess whether you might have been exposed to DES, as well as in-depth information for women prescribed DES while pregnant and their DES Daughters and DES Sons.
|
|
|
|
|
|
|
For Health Care Providers
 Resources to help identify and counsel DES-exposed individuals. Material includes essential facts for clinicians and nurses, pharmacology, NCI guidelines, educational tools and resources, and support organizations.
|
|
|
|
|
|
|
For DES Update Partners
 Tools to help you share information from the DES Update with your organization, including promotional materials, Web site linking kit, fact sheets and newsletter articles.
|
|
|
|
|
|
